Mendelspod

Happy National Podcast Day! We're talking with Ellen Matloff, CEO of MyGeneCounsel, about the evolving future of #geneticcounseling and #genetictesting on today's show. Ellen says big labs buying up the small is forcing genetic testing into the mainstream. https://lnkd.in/g-CNpwvT

As sequencing goes through another renaissance, Volta Labs, Inc. is shaking up sample prep with a new platform that will have many apps for all kinds of sequencing subspecialties, such as long reads. We talk with Udayan Umapathi, Founder and CEO, about his vision for innovating sequencing through sample prep. https://lnkd.in/gGVswite

Singular Genomics has introduced its dual purpose G4X capable of NGS and spatial multi-omics. We talk with CEO and Founder Drew Spaventa about the new possibilities for research this opens up. https://lnkd.in/gg55vnzf

This small lancet device collects whole vials of blood. Will it transform medicine through at-home testing? We talk with Ben Casavant Founder and CEO of Tasso, Inc. https://lnkd.in/g3T7V-QK

As part of "The New Biology" series, we talk with geneticist Kevin Mitchell about his new book making the evolutionary argument in favor of free will. The book is a tour de force, offering the captivating history of biology itself. https://lnkd.in/gU-4qPjY

Happy Proteomics Day! As #proteomics turns 30, we talk with Chris Whelan of Janssen Inc. and Founder and Chair of the Pharma Proteomics Project to ask: What’s Next for Large-Scale Proteomics? https://lnkd.in/gh9vsZSN

Happy Proteomics Day! As #proteomics turns 30, we talk with Chris Whelan of Janssen Inc. and Founder and Chair of the Pharma Proteomics Project to ask: What’s Next for Large-Scale Proteomics? https://lnkd.in/gh9vsZSN

New Approaches to Biology Headline our 14th Season Hello, world of biology and biomedicine! This week, we are pleased to announce our 14th season of Mendelspod. Wow. We began podcasting when sequencing a genome still cost $100,000. And it was long before Amazon was selling out of microphones and pajamas. We’ve been recording some great new content over the summer. Here’s a quick preview. Earlier today, we published an interview with biologist Michael Levin, a professor at Tufts University. This is the first show in a series we are calling ‘The New Biology.’ https://lnkd.in/d_wd3aWp Mike has questioned some of the basic assumptions in biology, the most important being that we need to unify biology with chemistry to conquer the field fully. Mike wants to remind everyone that this is an assumption. Biologists can pursue different directions non-reductionist directions. "I want to get across one very simple idea from which bioelectricity and a million other things flow—and I’m not the only one saying this—and that is the idea that the need to go down to the level of chemistry for understanding and control is just an assumption. It is not necessarily the optimal level,” he says. Also in this series, we’ll be talking with Kevin Mitchell, an Associate Professor of Genetics and Neuroscience at Trinity College in Dublin, who is out with a new book, "Free Agents: How Evolution Gave Us Free Will.”  An ambitious attempt to naturalize free will, the book turns into an outstanding history of biology and evolution, an absolute tour de force. Kevin, too, is a non-reductionist. And what of the reductionist gene-centric approach that we’ve all known and loved? We’ll be featuring a couple of geneticists, including Mendelpod return champion Nathan Pearson, on the path forward for genomics. More and more genomics researchers want to see protein data as well. This fall, we will continue our series on proteomics with Chris Whelan of Janssen R & D, the chair of the Pharma Proteomics Project. Chris says we are just beginning to see the breakthroughs in drug development that have come from the large-scale proteomics studies of the past couple of years.  So join us as we fire up the rockets to take off into the next frontier for biological research. Thank you for being the best part of Mendelspod, our listening audience. A special thanks to our paid subscribers, who have helped guarantee our continued journey into another year. Special thanks also to our sponsors, who bring us great content and help keep us on the air. If you’re interested in sponsorship, have a story to share, or represent anyone you think would make a great guest on the show, reach out to me at theraltimpson AT gmail DOT com. If you have been a free subscriber, please consider a paid membership for the price of a couple of coffees per month. Your support means everything to us!

New Approaches to Biology Headline our 14th Season Hello, world of biology and biomedicine! This week, we are pleased to announce our 14th season of Mendelspod. Wow. We began podcasting when sequencing a genome still cost $100,000. And it was long before Amazon was selling out of microphones and pajamas. We’ve been recording some great new content over the summer. Here’s a quick preview. Earlier today, we published an interview with biologist Michael Levin, a professor at Tufts University. This is the first show in a series we are calling ‘The New Biology.’ https://lnkd.in/d_wd3aWp Mike has questioned some of the basic assumptions in biology, the most important being that we need to unify biology with chemistry to conquer the field fully. Mike wants to remind everyone that this is an assumption. Biologists can pursue different directions non-reductionist directions. "I want to get across one very simple idea from which bioelectricity and a million other things flow—and I’m not the only one saying this—and that is the idea that the need to go down to the level of chemistry for understanding and control is just an assumption. It is not necessarily the optimal level,” he says. Also in this series, we’ll be talking with Kevin Mitchell, an Associate Professor of Genetics and Neuroscience at Trinity College in Dublin, who is out with a new book, "Free Agents: How Evolution Gave Us Free Will.”  An ambitious attempt to naturalize free will, the book turns into an outstanding history of biology and evolution, an absolute tour de force. Kevin, too, is a non-reductionist. And what of the reductionist gene-centric approach that we’ve all known and loved? We’ll be featuring a couple of geneticists, including Mendelpod return champion Nathan Pearson, on the path forward for genomics. More and more genomics researchers want to see protein data as well. This fall, we will continue our series on proteomics with Chris Whelan of Janssen R & D, the chair of the Pharma Proteomics Project. Chris says we are just beginning to see the breakthroughs in drug development that have come from the large-scale proteomics studies of the past couple of years.  So join us as we fire up the rockets to take off into the next frontier for biological research. Thank you for being the best part of Mendelspod, our listening audience. A special thanks to our paid subscribers, who have helped guarantee our continued journey into another year. Special thanks also to our sponsors, who bring us great content and help keep us on the air. If you’re interested in sponsorship, have a story to share, or represent anyone you think would make a great guest on the show, reach out to me at theraltimpson AT gmail DOT com. If you have been a free subscriber, please consider a paid membership for the price of a couple of coffees per month. Your support means everything to us!

We're very excited to launch our 14th Season with Michael Levin of Tufts University School of Medicine on his breakthrough ideas for biomedicine. Mike’s less traveled path is focused on the innate intelligence of tissues and organs. He argues that networks of cells are goal-oriented and achieve their goals through the medium of bioelectricity, a kind of proto-brain.  He knows that terms like "intelligence” and “goal” are taboo in the field and insists on fundamental basic definitions for the terms. The idea is to go in and “reprogram” the goals of a group of cells and let them do the work of reversing disease. Talk about gene therapy—Mike says he can imagine biological machines that are already in our bodies finding and repairing damaged DNA, tissue, and organs. It's great to see biologists taking some new non-reductive approaches! https://lnkd.in/d_wd3aWp